Intérêt du TEP-FDG dans la prise en charge des métastases des cancers urologiques

25 novembre 2008

Auteurs : P. Labarthe, A. Méjean, T. Lebret
Référence : Prog Urol, 2008, 18, S208, suppl. S7


Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser






Hain S.F. Positron emission tomography in uro-oncology Cancer Imaging 2005 ;  5 (1) : 1-7Jan 17.  [cross-ref]
Bourguet P., Planchamp F., Montravers F., et al. Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles and the urinary bladder Bull Cancer 2006 ;  93 : 1128
Mejean A., Correas J.M., Escudier B., de Fromont M., Lang H., Long J.A., Neuzillet Y., Patard J.J., Piechaud T. Recommandations 2007 en onco-urologie. AFU, SFRO, GETUG, SFP Prog Urol 2007 ;  66 : 1009-1044
Kang D.E., White R.L., Zuger J.H., Sasser H.C., Teigland C.M. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma J Urol 2004 ;  171 (5) : 1806-1809 [cross-ref]
Kaneta T., Hakamatsuka T., Yamada T., Takase K., Sato A., Higano S., Kinomura S., Fukuda H., Takahashi S., Yamada S. FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature Ann Nucl Med 2006 ;  20 (1) : 79-82 [cross-ref]
Jadvar H., Kherbache H.M., Pinski J.K., Conti P.S. Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma Clin Nephrol 2003 ;  60 (6) : 395-400 [cross-ref]
Chang C.H., Wu H.C., Tsai J.J., Shen Y.Y., Changlai S.P., Kao A. Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostatespecific antigen relapse after treatment for localized prostate cancer Urol Int 2003 ;  70 (4) : 311-315 [cross-ref]
Majhail N.S., Urbain J.L., Albani J.L., Kanvinde M.H., Rice T.W., Novick A.C., Mekhail T.M., Olencki T.E., Elson P., Bukowski R.M. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma J Clin Oncol 2003 ;  21 : 3995-3998 [cross-ref]
Lawrentschuk N., Poon A.M., Scott A.M. Fluorine-18 fluorothymidine: a new positron emission radioisotope for renal tumors Clin Nucl Med 2006 ;  31 : 788
Effert P.J., Bares R., Handt S., Wolff J.M., Bull U., Jakse G. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose J Urol 1996 ;  155 : 994-998 [cross-ref]
Powles T., Murray I., Brock C., Oliver T., Avril N. Molecular positron emission tomography and PET/CT imaging in urological malignancies Eur Urol 2007 ;  51 (6) : 1511-1520
Haseman M.K., Reed N.L., Rosenthal S.A. Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen: positron emission tomography and biopsy correlation Clin Nucl Med 1996 ;  21 : 704-713 [cross-ref]
Kotzerke J., Prang J., Neumaier B. Experience with carbon-11 choline positron emission tomography in prostate carcinoma Eur J Nucl Med 2000 ;  27 : 1415-1419 [cross-ref]
Morris M.J., Akhurst T., Larson S.M. Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy Clin Cancer Res 2005 ;  11 : 3210-3216 [cross-ref]
Cimitan M., Bortolus R., Morassut S. 18F-fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients Eur J Nucl Med Mol Imaging 2006 ;  33 : 1387-1398 [cross-ref]
Gofrit O.N., Mishani E., Orevi M. Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma J Urol 2006 ;  176 : 940-944 [cross-ref]
De Santis M., Becherer A., Bokemeyer C., Stoiber F., Oechsle K., Sellner F. 2-18 fluoro-deoxy-D- glucose positon emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trials J Clin Oncol 2004 ;  22 : 1034-1039 [cross-ref]
Scher B., Seitz M., Albinger W., Reiser M., Schlenker B., Stief C., Mueller-Lisse U., Dresel S. Value of PET and PET/CT in the diagnostics of prostate and penile cancer Recent Results Cancer Res 2008 ;  170 : 159-179 [cross-ref]


© 2008  Elsevier Masson SAS. Tous droits réservés.